FDA Inspections Unlikely Following Documented Manufacturing Changes

FDA normally will not inspect the facilities of device companies with an approved PMA that report changes in manufacturing procedures via 30-day notices unless the Center for Devices and Radiological Health "determines that the notice is inadequate," the agency explains in a recent guidance.